These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 1671855)

  • 1. Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells.
    Tomida A; Tatsuta T; Suzuki H
    Jpn J Cancer Res; 1991 Jan; 82(1):127-33. PubMed ID: 1671855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytocidal activity of a synthetic isoprenoid, N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, and its potentiation of antitumor drugs against multidrug-resistant and sensitive cells in vitro.
    Suzuki H; Tomida A; Nishimura T
    Jpn J Cancer Res; 1990 Mar; 81(3):298-303. PubMed ID: 2161816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect in culture of bleomycin-group antibiotics and N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine, a synthetic isoprenoid.
    Tomida A; Suzuki H
    Jpn J Cancer Res; 1990 Nov; 81(11):1184-90. PubMed ID: 1702416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isoprenoid analogues of SDB-ethylenediamine on multidrug resistant tumor cells alone and in combination with chemotherapeutic drugs.
    Sidorova TA; Nigmatov AG; Kakpakova ES; Stavrovskaya AA; Gerassimova GK; Shtil AA; Serebryakov EP
    J Med Chem; 2002 Nov; 45(24):5330-9. PubMed ID: 12431060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
    Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y
    Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport of the multidrug resistance modulators verapamil and azidopine in wild type and daunorubicin resistant Ehrlich ascites tumour cells.
    Sehested M; Skovsgaard T; Jensen PB; Demant EJ; Friche E; Bindslev N
    Br J Cancer; 1990 Jul; 62(1):37-41. PubMed ID: 1975202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by verapamil of neocarzinostatin action on multidrug-resistant Chinese hamster ovary cells: possible release of nonprotein chromophore in cells.
    Miyamoto Y; Maeda H
    Jpn J Cancer Res; 1991 Mar; 82(3):351-6. PubMed ID: 1673676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined effect of bleomycin and SDB-ethylenediamine, a synthetic isoprenoid, on oral squamous carcinoma cell lines and transplantable nude mouse tumors].
    Takahashi Y; Urade M; Kishimoto H; Arimoto T; Yanagisawa T; Yoshioka W
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):883-7. PubMed ID: 7540824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S; Pierré A; Anstett M; Pérez V; Genton A; Bizzari JP; Atassi G
    Biochem Pharmacol; 1992 Nov; 44(9):1707-15. PubMed ID: 1360210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.
    Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S
    Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line.
    Nakagawa M; Akiyama S; Yamaguchi T; Shiraishi N; Ogata J; Kuwano M
    Cancer Res; 1986 Sep; 46(9):4453-7. PubMed ID: 3731102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of P-glycoprotein with a hydrophobic component of rat urine.
    Charuk JH; Reithmeier RA
    Biochem Biophys Res Commun; 1992 Jul; 186(2):796-802. PubMed ID: 1353959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of P-glycoprotein-mediated paclitaxel resistance by new synthetic isoprenoids in human bladder cancer cell line.
    Enokida H; Gotanda T; Oku S; Imazono Y; Kubo H; Hanada T; Suzuki S; Inomata K; Kishiye T; Tahara Y; Nishiyama K; Nakagawa M
    Jpn J Cancer Res; 2002 Sep; 93(9):1037-46. PubMed ID: 12359058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionally active homodimer of P-glycoprotein in multidrug-resistant tumor cells.
    Naito M; Tsuruo T
    Biochem Biophys Res Commun; 1992 May; 185(1):284-90. PubMed ID: 1350903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
    Greenberger LM; Yang CP; Gindin E; Horwitz SB
    J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
    Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
    Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.